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Abstract
Background: Family members are often required to act as substitute decision-makers when health care or
research participation decisions must be made for an incapacitated relative. Yet most families are unable to
accurately predict older adult preferences regarding future health care and willingness to engage in research
studies. Discussion and documentation of preferences could improve proxies’ abilities to decide for their loved
ones. This trial assesses the efficacy of an advance planning intervention in improving the accuracy of substitute
decision-making and increasing the frequency of documented preferences for health care and research. It also
investigates the financial impact on the healthcare system of improving substitute decision-making.
Methods/Design: Dyads (n = 240) comprising an older adult and his/her self-selected proxy are randomly
allocated to the experimental or control group, after stratification for type of designated proxy and self-report of
prior documentation of healthcare preferences. At baseline, clinical and research vignettes are used to elicit older
adult preferences and assess the ability of their proxy to predict those preferences. Responses are elicited under
four health states, ranging from the subject’s current health state to severe dementia. For each state, we estimated
the public costs of the healthcare services that would typically be provided to a patient under these scenarios.
Experimental dyads are visited at home, twice, by a specially trained facilitator who communicates the dyad-
specific results of the concordance assessment, helps older adults convey their wishes to their proxies, and offers
assistance in completing a guide entitled My Preferences that we designed specifically for that purpose. In between
these meetings, experimental dyads attend a group information session about My Preferences. Control dyads attend
three monthly workshops aimed at promoting healthy behaviors. Concordance assessments are repeated at the
end of the intervention and 6 months later to assess improvement in predictive accuracy and cost savings, if any.
Copies of completed guides are made at the time of these assessments.
Discussion: This study will determine whether the tested intervention guides proxies in making decisions that
concur with those of older adults, motivates the latter to record their wishes in writing, and yields savings for the
healthcare system.
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Background
The potential value of advance planning
As the population ages worldwide, growing numbers of
older adults develop Alzheimer’s disease and related dis-
orders that gradually impair their decision-making capa-
city [1]. As a result, important health-related decisions
end up being made by family members and healthcare
providers without direct input from the affected indivi-
dual [2]. Recent data from the Health and Retirement
Study indicate that 40% of decedents require decision
making about treatment in the final days of life, of whom
70% lack decision-making capacity [3]. In the context of
dementia research, family members are also often soli-
cited for permission to enroll a cognitively-impaired rela-
tive in a study with little likelihood of personal benefit
[4,5]. Such decision-making is all the more difficult when
the wishes of the decisionally-impaired person have
never been documented or discussed with family mem-
bers. Indeed, the scientific literature provides ample evi-
dence that close relatives are unable to accurately predict
elderly patients’ preferences for care [6] and willingness
to engage in clinical studies of varying levels of risk and
benefit [7-9].
Advance planning has been widely promoted as a
mechanism to guide families toward decisions similar to
those an incapacitated relative would have made, had he/
she still been able to decide. Advance planning aims at
helping people clarify and communicate their values,
beliefs and preferences for future care in the event of
impaired decisional capacity [10-12]. Led by a trained
facilitator, the process involves exploring goals of care in
the context of hypothetical illness states. It ideally
includes a close family member likely to be involved in
decision-making when the patient is incapacitated. Ensu-
ing wishes, called advance directives (ADs), may or may
not be conveyed in writing. Written ADs for health care
are documents in which capable individuals specify their
preferences regarding treatment and/or designate a
trusted relative or friend to eventually make decisions for
them should they lose the ability to express themselves
[13]. When including a section devoted to research [14],
written ADs serve the extended purpose of instructing
others as to their desire to engage or not in research at
times of incapacity [15,16].
Surveys have repeatedly found overwhelming support
for ADs, whether communicated in writing or more infor-
mally through conversations with families and health pro-
fessionals [17,18]. Major professional organizations also
support advance planning for health care and research
[19-21]. Widespread endorsement of ADs is due to their
potential to preserve patient autonomy, improve end-of-
life medical care, alleviate the burden of substitute deci-
sion-making for loved ones, reduce stress, anxiety and
depression in surviving relatives, and limit the use of
unwanted forms of life-support. ADs may also result in
more cost-effective health care by discouraging physicians
from resorting to unwanted treatment [17,18,22,23].
Despite widespread professional and public endorsement
of ADs for health care, still too few people actually execute
them or even discuss future treatment wishes with loved
ones or healthcare practitioners [2,18,22,24,25]. The most
common reasons include trusting family members to
make the right decision when the time comes, the
tendency to defer end-of-life planning until facing a life-
threatening illness, a lack of knowledge about ADs, and
limited access to needed forms [11]. According to our
own survey [25], even fewer have voiced their wishes in
relation to research involvement. Interestingly, survey par-
ticipants who had done so were more likely to have con-
veyed their preferences for care. Accordingly, dedicating a
section of AD forms to the person’s wishes regarding
health research participation could prove effective in
increasing the frequency of prospective authorization for
research participation [26,27].
Improving proxy predictions of preferences
Numerous studies have shown that proxy predictions of
patient preferences for health care are inaccurate [6].
Creative approaches aimed at improving the accuracy of
substitute judgment thus need to be developed and eval-
uated. Most promising approaches include promoting
explicit communication between older adults and proxies
regarding future medical care, and encouraging patients
to document their preferences. The former proposition
follows from the repeated observation that prior discus-
sions between patients and proxies about treatment pre-
ferences often lead to higher levels of agreement [6,28].
This finding, which stems primarily from cross-sectional
studies, needs to be confirmed using stronger designs. At
the time of funding, four randomized controlled trials
had tested the hypothesis that facilitating discussions
about preferences improves the accuracy of surrogate
decisions [10,29-31]. A fifth randomized trial was pub-
lished one year later [32].
Matheis-Kraft & Roberto [29] investigated whether prior
discussions of value indicators by older women and their
proxies increased the abilities of the latter to make 30
hypothetical healthcare decisions in congruence with
those of the women. The experimental dyads (n = 30) did
not demonstrate statistically higher agreement than their
control counterparts (n = 30) in 27 of the 30 situations.
The intervention designed by Ditto et al. [30] also failed
to improve proxies’ predictive abilities. Investigators con-
cluded that their findings provide an “unequivocal demon-
stration of the ineffectiveness of patient-surrogate
discussion to enhance the accuracy of substitute judg-
ment”. This conclusion may be premature, however,
because the intervention was too weak to produce its
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intended effect. It essentially involved asking patients to
complete an AD form in the presence of the surrogate and
explain the reasons underlying their choices. Hence
patients randomized to the intervention group (n = 80)
were required to develop a written plan of their wishes,
whether or not they had reflected on their personal goals
of care and were emotionally ready to commit their prefer-
ences in writing. Furthermore, as acknowledged by the
authors themselves, the intervention was restricted to a
brief, single-session discussion without any explicit educa-
tional component on ADs.
Pearlman and collaborators [10] randomized 184 deci-
sionally-competent veteran outpatients who did not have
ADs in their hospital record. Experimental subjects were
mailed a 52-page advance planning workbook and
attended a 30-minute counseling session led by social
workers immediately prior to their scheduled appointment
with their healthcare providers. Control subjects were
mailed the hospital’s 8-page AD booklet 5 weeks prior to
their office visit. Both books contained blank AD forms to
complete. Four months after the index visit, ADs were
filed in the medical chart twice as often for the interven-
tion group (48% vs. 23%, p < 0.001). In addition, healthcare
providers were more accurate in predicting the experi-
mental subjects’ treatment preferences, values and perso-
nal beliefs than for controls (p < 0.01 for all three
comparisons). Patient-proxy concordance scores did not
differ between intervention and control groups for prefer-
ences and values, but were higher in the intervention
group for personal beliefs (67% vs. 56%, p = 0.04). Two
features of the intervention may explain the better perfor-
mance of healthcare providers over proxies. Providers
were prompted to discuss planning with experimental sub-
jects and had full access to their medical records, including
any directives therein. By contrast, no component of the
intervention promoted patient-proxy discussion which
was entirely left to the patients’ discretion. As stated by
the authors: “this suggests that specific efforts should be
made to include proxies in advance planning discussions
with the patients”.
Schwartz et al. [31] tested whether advance planning
facilitated by a trained professional leads to greater
understanding by proxies of patients’ end-of-life prefer-
ences. The control group received a healthcare proxy
form to fill out. By contrast, experimental subjects were
first handed written information on ADs to be shared
with their proxies. Patient-proxy dyads later attended one
to two sessions with the facilitator who discussed the
benefits and burdens of life-support and documented
patient’s goals and preferences therefore. Greater concor-
dance was observed among experimental dyads two
months post-intervention (Cohen’s effect size [ES] =
0.43), a result later confirmed by Gutheil & Heyman [33]
(ES = 0.48) using a quasi-experimental design. Effect
sizes were not statistically significant due to the small
sample sizes (less than 30 dyads per arm). Nonetheless,
these studies provide some evidence of the likely benefit
of an intervention that combines two strategies pre-
viously tested separately: the provision of educational
materials on ADs and a facilitated discussion within
elderly-proxy dyads about the older adult’s values, goals
and preferences for end-of-life care.
Lastly, Barrio-Cantalejo et al. [32] randomized 171
pairs of patients and their respective proxies to one of
three study groups. The control group’s answers to the
Life Sustaining Preferences Questionnaire (LSPQ) devel-
oped by Beland & Froman [34] were compared with their
proxies’ answers to the same questionnaire. In one inter-
vention group, proxies used the patients’ completed AD
form to fill in the LSPQ. In the second intervention
group, patients and proxies jointly attended two educa-
tive sessions with a trained nurse before filling in the
LSPQ in separate rooms. The first session was informa-
tive and focused on healthcare decisions at the end of
life. In the second session, the nurse encouraged each
dyad to discuss preferences in different medical scenar-
ios. Accuracy in the discussion group (84.5%) was higher
than that observed in the two other study groups (50.34%
and 58.3%, respectively). Findings suggest that stimulat-
ing dialogue between patients and their proxies about
end-of-life preferences improves the accuracy of proxies’
predictions much more than isolated use of an AD form.
Whether further improvement could be achieved by
combining AD forms with discussions remains to be
investigated.
No study has yet tested the effect of an intervention in
improving family members’ abilities to predict their rela-
tive’s willingness to engage in clinical research. Such a
study is needed in light of increasing research involving
cognitively-impaired older adults [35,36]. Until effective
treatments for Alzheimer’s disease and related disorders
are discovered, clinical research efforts to uncover the
causes of such diseases, prevent their onset or halt their
progression, will in part depend on the direct participa-
tion of cognitively-impaired subjects. However, unlike
health care, which is intended to directly benefit the
patient, the overriding objective of research is to further
knowledge irrespective of any direct benefits the partici-
pant may stand to gain. As for health care, most family
members are unable to accurately predict their relative’s
desire to engage in research [7-9]. Nonetheless,
researchers turn to them for permission to enrol deci-
sionally-incapacitated prospective subjects [5]. Besides,
surveys have repeatedly shown that most people would
trust their family to make research-related decisions on
their behalf, should the need arise [26,37,38].
To our knowledge, the study by Pearlman et al. [10] is
the only one that simultaneously tested the effects of
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patient-proxy advance planning discussions on predic-
tion accuracy and rate of written ADs. Furthermore, we
are aware of only one empirical test of ADs for demen-
tia research [15]. As in other studies [29,30], experimen-
tal subjects had to complete the directive, which
entailed expressing their willingness to enrol or not in
five hypothetical research studies. At follow-up, investi-
gators examined the effect of the directive on ease of
enrolment decisions in actual studies. Change in proxy
accuracy resulting from completing the directive has not
been reported. Results are nonetheless relevant to our
study as it proved the feasibility of research ADs and
willingness of participants to communicate the range of
risks they would be willing to assume should they lose
decisional capacity and be solicited for research.
Results from recent systematic reviews
One systematic review has been conducted on surro-
gates’ predictive accuracy [6]. It included 16 studies
involving 2,595 surrogate-patient pairs asked to make
end-of-life treatment decisions in the context of various
hypothetical scenarios. Overall, surrogates predicted
patients’ treatment preferences with 68% accuracy (95%
CI: 63% to 72%). Surrogates were more accurate in sce-
narios involving the patient’s current health (79%) than
in those involving dementia (58%, p < 0.05). Furthermore,
one-time informal conversations about patients’ prefer-
ences were not found to improve surrogate predictive
abilities. This review points to the need to find ways to
improve surrogates’ predictive accuracy, especially under
scenarios of altered cognitive states.
We published the latest systematic review of the effec-
tiveness of interventions in promoting ADs for health
care [39]. Our review includes 55 studies involving
12,691 subjects. Across the 11 randomized trials, the
pooled odds ratio for written ADs was 4.0 (95% CI: 1.6-
10.4). The intensity of the intervention had the most
influence on event rates (p < 0.001). Furthermore, the
provision of oral information (p = 0.039) over multiple
sessions (p = 0.009) was the main feature of successful
interventions. This finding concurs with that of other sys-
tematic reviews [40], despite differences in methodologi-
cal approaches.
In summary, the most recent data available strongly
suggest that interventions most likely to be successful in
improving surrogates’ predictive abilities: involve struc-
tured discussions about values and preferences for end-
of-life care that go beyond AD completion, are led by
trained facilitators, span several sessions, include proxies,
and comprise an educational component. Professionally
led, multimodal interventions delivered over multiple ses-
sions were also those found most effective in increasing
the frequency of written ADs. Our multimodal interven-
tion was designed along these lines.
The Quebec legal landscape regarding substitute
decision-making
In the province of Quebec, Canada, where this trial is
conducted, family members are legally authorized to
make healthcare decisions for incapable relatives even
when not formally appointed to do so through a court
ruling (article 15 of the Quebec Civil Code). According
to article 12, “a person who gives his consent to or
refuses care for another person is bound to act in the
sole interest of that person, taking into account, as far as
possible, any wishes the latter may have expressed”. Yet
wishes cannot be taken into account if they have never
been communicated to those likely to make substitute
decisions. In a recent qualitative study [41], over 70% of
family members of a person with advance dementia
reported not knowing the healthcare preferences of their
relative. Nearly two-thirds of those who had not dis-
cussed preferences with their relative wished they could
go back to a time when he/she had less cognitive impair-
ment and have the conversation. Furthermore, according
to a survey conducted among geriatricians [42], access to
written ADs greatly facilitated their discussions about
end-of-life care with patients and relatives, even though
these directives had not come into effect. Hence, despite
not being legally binding in Quebec, prior statements of
preferences could be of great assistance to substitute
decision-makers and providers when healthcare decisions
must be made for incapable patients.
In contrast to health care, consent to non-emergency
research for an incapacitated individual can only be given
by that person’s court-appointed representative (article
21 of the Quebec Civil Code). Yet very few decisionally-
incapacitated elders have a court-appointed representa-
tive. According to our survey [4], 74.6% of researchers
proceed with the consent of a family member, whether
legally appointed or not. Moreover, Institutional Review
Boards are open to the enrolment in research of incapaci-
tated subjects who do not have a legal representative
[4,5]. Thus it is crucial for older adults to inform close
family members of the types of research they are willing
to take part in, should they be solicited for research after
losing decisional capacity.
The research objectives
The purpose of this trial is to assess the efficacy of a multi-
modal professionally-led advance planning intervention in
1) improving the accuracy of substitute decision-making
(primary outcome) and 2) increasing the frequency of
written ADs for health care and research (secondary out-
come). Given current knowledge, the tested intervention
includes an educational component on ADs and stimu-
lates discussion between an older adult and his/her self-
selected proxy with respect to end-of-life care and
research participation. The study incorporates a cost
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analysis to measure public savings that result from
improving proxy predictions of preferences.
Methods/Design
Design and target population
The efficacy of the proposed intervention in improving
prediction accuracy of substitute decision-making is
assessed through a single-blind, stratified, randomized
controlled trial with prediction accuracy measured at
baseline, at the end of the intervention and 6 months
later.
The study population is formed of dyads comprising a
decisionally-competent older adult and the person he/she
would choose to make healthcare decisions on his/her
behalf in the event of incompetence (called “the proxy”).
Eligible older adults are community-dwelling, French-
speaking individuals aged 70 and over who live in the
Eastern Townships of the province of Quebec and are
likely free of cognitive deficits. Eligible proxies must live
in the same region and be fluent in French.
Dyads are randomly assigned to the intervention or
control group after stratification for two factors that may
influence the success of the intervention: type of desig-
nated proxy (spouse vs. other) and self-report by the
older adult of prior documentation of healthcare prefer-
ences (yes vs. no). Group allocation is made by reference
to computer-generated blocked randomization lists pre-
pared by a team member who has no involvement in
delivering the interventions. Random block sizes from 2
to 8 were used within strata to reduce the predictability
of group assignment and balance the number of dyads
per arm.
Recruitment process
Prospective subjects are identified from a random list
containing the names, sex and addresses of older adults
meeting the first four inclusion criteria. The list was
extracted from the provincial administrative database
containing all beneficiaries of the Quebec universal
health insurance plan.
Potential participants are mailed an introductory letter
and contacted one week later by the study coordinator
who states the purpose of the call, describes how they
were chosen and asks for verbal consent to proceed with
a short interview. Reasons for not being interviewed (e.g.,
ineligibility, hearing impairment, refusals) are recorded.
Refusers are asked to provide limited descriptive infor-
mation about themselves for comparison with those who
consent to the interview. A 3-item memory test is admi-
nistered to screen out elders who are likely unable to par-
ticipate actively in a discussion about their preferences.
Older adults excluded because of cognitive impairments
are contacted in the following days by a co-investigator
to determine how best to assist those in need (e.g.,
through referral to healthcare providers). Those deemed
eligible are invited to participate in the study, which
entails designating the person whom they would choose
to make healthcare decisions on their behalf in the event
of future incompetence. Designated proxies are then con-
tacted by the study coordinator to ascertain their eligibil-
ity and own willingness to participate.
Prior to randomization, baseline levels of concordance
are established for each eligible and consenting dyad, as
follows.
Baseline concordance assessment
Baseline data are gathered during two face-to-face inter-
views conducted one week apart by specially trained
research nurses who have no involvement in delivering
the intervention. The first interview focuses on treat-
ment decisions and the second, on decisions regarding
research participation. Interviews are conducted simulta-
neously, with the elderly person and proxy in separate
rooms of the Research Center so that responses are not
cross-contaminated.
The first interview begins by asking dyad members to
read and sign the informed consent form. Next, the
research nurses collect usual socio-demographic data on
dyad members, as well as health-related information
about the older adult. They then explore various factors
that may influence the outcome measures, including
personal experience with life-threatening illness, desired
level of control in decision-making, and comfort with
substitute decision-making. Where relevant, matching
questions are administered to the proxies.
The core of the interviews consists of hypothetical clin-
ical and research vignettes specifically designed to elicit
older adult preferences and assess the ability of their
proxy to predict these preferences. Vignettes are modeled
on those developed and validated by us and others
[7-9,43-45] in previous research on substitute decision-
making. Responses are elicited under four health states:
1) the subject’s current health state, 2) as if he/she had
sustained a light to moderate stroke, 3) as if he/she had
an incurable brain cancer, and 4) as if he/she had severe
dementia. The concordance assessment begins by asking
older adults to imagine themselves in each of these states
and select the answers that best describe their quality of
life under these states (from excellent to poor). Then, for
each health state, they are asked to indicate whether they
would want to receive each of five life-sustaining treat-
ments (antibiotics, CPR, etc.). The same exercise is
repeated at the second interview, this time seeking the
older adults’ willingness to enroll in each of three
research protocols (blood sample, supervised exercise
program, and oral medication trial). These protocols are
designed to cover a broad range of risks and benefits (to
the subject or others) in order to elicit an equally broad
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spectrum of willingness to participate. Older adults are
also asked to select one out of four goals of care (from
palliative care to intensive care) for different sudden
health events (pneumonia, hemorrhagic shock, and
severe head trauma). Health events were chosen to cap-
ture a wide range of conditions varying in severity, nature
of impairment, and prognosis. To ensure understanding,
health states, treatment modalities, research protocols
and critical events are described briefly and simply by the
research nurse using written materials handed out during
training. Using identical response scales, proxies are
asked to choose the decision they think the older adult
will make in each situation (substituted judgment) or, if
unable to do so, to make a decision based on the older
adult’s best interests. Concordance assessments were pre-
tested on three potential dyads and subsequently revised
for clarity. Results are compiled as soon as the interviews
are completed, and communicated to experimental dyads
at the start of the intervention.
Trial interventions
Intervention in the experimental group
The proposed intervention was designed from literature
reviews [6,39,40] and recent experimentations [31,33]. It
integrates multiple methods to increase learning [46] and
uses teaching tools adapted to normal aging changes
[47]. The intervention consists of 2-hour meetings, once
monthly, over three months. The duration of the inter-
vention follows from the need for an incremental process
that enables older adults to articulate preferences at their
own pace and gradually integrate information on the
benefits and limitations of ADs [28]. Furthermore, we
expect repeated encounters to foster trusting relation-
ships between dyad members and research personnel
that are conducive to discussions on issues as sensitive as
end-of-life care. The first and third meetings take place
in the home of the older adult or proxy, a strategy likely
to counter attrition [31]. The second meeting is an infor-
mation session on ADs for groups of dyads.
Home meetings are led by trained social workers with
extensive experience working with elders. The first visit
begins with two thought-provoking vignettes that high-
light the importance of communicating one’s wishes
about future medical care and research participation. The
use of vignettes illustrating real-life experience has been
shown to increase learning in elderly populations [47].
After eliciting reactions to the vignettes and exploring
related issues, the facilitator summarizes the dyad-speci-
fic results of the concordance assessment and invites
dyad members to discuss the reasons underlying their
choices. Discussions seek to help older adults describe
what makes their life worth living in specific, functional
terms [48] and articulate their wishes, personal values
and beliefs, so as to guide proxies in making decisions for
them. Throughout the intervention, the social worker
catalyzes discussion so that a shared understanding gra-
dually develops between the older adult and his/her
proxy.
The AD information session focuses on a guide entitled
My Preferences that we designed for expressing wishes
regarding future health care and research involvement.
My Preferences also invites the signer to designate substi-
tute decision-makers should he/she become incompetent.
It was adapted from an AD form developed by Molloy
and collaborators [49] for the Let Me Decide (LMD) pro-
ject. The LMD form has been successfully implemented
in nursing homes and the community [50-53]. My Prefer-
ences was also inspired by documents developed by
others for the same purpose [44,54,55]. Adaptation
involved describing Quebec’s legislation regarding substi-
tute decision-making and adding a section for expressing
desire to engage or not in studies of varying levels of risk
and benefit.
My Preferences contains information on the purposes
and uses of ADs. It addresses their practical limitations,
including the impossibility of anticipating all future med-
ical events [56-58]. The importance of reviewing ADs
periodically is underscored given that preferences may
change with the occurrence of significant life events, as
predicted by the response shift theory [22,59,60]. More
importantly, My Preferences emphasizes the difference
between healthcare and research ADs so that subjects
understand that research aims primarily at advancing
knowledge for the benefit of future patients.
My Preferences was designed to be attractive to and
effective with older adults [46,47,61]. It requires no more
than 30 minutes to read and includes features such as:
■ paper with a matte surface,
■ contrasted background and text,
■ font size no smaller than 13 points,
■ short sentences using words as simple as possible,
■ glossary with medical and technical term
definitions,
■ main idea of each paragraph highlighted in a box,
■ many illustrations,
■ space to write down instructions.
Before its use in the study, My Preferences was pre-
sented to 10 persons and subsequently revised for
clarity.
The learning environment for the information session is
also adapted for the elderly: a large, well-lit room allowing
participants to move around easily, small group setting
with chairs in a U shape layout to encourage interaction
and discussion [47,62,63]. Various effective teaching tools
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are used throughout the information session [47,48,62-65],
including:
■ a quiz to introduce and help assimilate new
information,
■ a PowerPoint presentation in bright colors with
large text,
■ videos showing people sharing their experiences
(e.g., a person expressing difficulties due to not
knowing the wishes of a loved one, a physician
explaining the importance of advance planning for
health care) or explaining how to use My Preferences
to convey their wishes to family members,
■ activities encouraging participants to express their
own point of view and to start completing My Pre-
ferences which then serves as an external memory
aid to help overcome deficits in memory processes
that are frequent among older adults.
At the third and final meeting, the social worker checks
subjects’ understanding of the information delivered at the
group session, explains any terms in My Preferences that
are still unfamiliar to the participants, and assists older
adults in filling one out if desired. Those who elect to
complete My Preferences at this stage are advised to
inform family members and designated substitute deci-
sion-makers of its location and content. The social worker
then requests a copy for analysis purposes. Content ana-
lyses of completed guides will allow us to determine
whether the older adult designated a substitute decision-
maker and/or expressed preferences regarding health care
and research participation. Lastly, the social worker
explores participants’ satisfaction with the process and col-
lects any suggestions they might have on how to improve
the intervention.
Intervention in the control group
Approximately once monthly over three months, dyads
assigned to the control group are invited to attend a 2-
hour health education workshop on healthy lifestyle and
preventive practices. The three workshops are adapted
from a health education program aimed at improving
self-care skills that has been effective with elderly people
[66]. The number of meetings between dyads and the
research team is identical across groups. However,
experimental dyads meet individually and in subgroups
whereas controls always convene in subgroups. Health
education workshops are given by experienced nurses
and allow for interaction within and between dyads.
Once the study is complete, the AD information session
given to experimental dyads will be offered to controls.
Primary and secondary outcome measures
Prediction accuracy of substitute decision-making is the
primary outcome and rate of completed guides, the
secondary outcome. Concordance is the most important
outcome of advance planning activities. However, we
consider important to also measure the rate of docu-
mented preferences as these could raise less controversy
in the event of incompetence than oral instructions
given only to a single family member.
Concordance assessments are repeated at the end of
the intervention (first posttest) and 6 months later (sec-
ond posttest), according to the same procedure as at
baseline. However, the first posttest uses new sets of
treatments, sudden health events and research protocols
to counter recall bias. Older adults’ decisions under these
various scenarios, and their proxies’ predictions concern-
ing those decisions, are recorded by the same research
nurses who interviewed them at baseline. The second
posttest will allow us to determine whether the positive
effect of the intervention on prediction accuracy, if any,
is maintained for at least six months. Copies of com-
pleted My Preferences are made at the first posttest and,
for those who have yet to complete one, at the second
posttest. Allocating six months to fill out My Preferences
gives participants extra time to decide whether they want
to commit directives in writing. A longer interval carries
the risk of losing too many participants and no longer
permits attributing the observed effect to the interven-
tion, as opposed to more recent events that might have
occurred in the meantime. Evidence regarding the impact
of the intervention on the rate of completed guides will
be based on written documents rather than self-report as
the latter was found to overestimate true completion
rates [39].
Cost Analysis
To measure the intervention’s financial impact, we will use
the goals of care chosen by the older adults and their
proxies at baseline and at the second posttest for the var-
ious health events. These goals of care will have been
transformed into costs previously. The differential cost
between the decisions made at baseline by the older adults
in the experimental group and those made by their proxies
for all scenarios will be deducted from the differential cost
at posttest 2. To establish the net effect, the results will be
compared with those of the control group calculated with
the same method.
Three steps are required to cost each of the possible
healthcare scenarios (health states × goals of care ×
health events): 1) identifying the healthcare resources
required; 2) measuring the amount of resources pre-
viously identified; and 3) costing each resource [67,68].
As in previous studies [53,69,70], to identify the
resources to be costed, we considered the health care and
services that could be influenced by the preferences of
the older adults or their proxies and could thus generate
different costs. Therefore, we will value the healthcare
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services delivered essentially by the public healthcare sys-
tem: hospital stays, nursing and assisted care, general and
specialized medical care, ambulance transportation and
other direct or indirect treatment-related costs. We will
disregard healthcare services provided by family members
on a volunteer basis.
To determine the number of resources required, we
asked three physicians to create a treatment profile for
each scenario, which were later validated from existing
care protocols [71-78]. Relying on their expertise and
experience, the physicians established a list of healthcare
services based on the most frequent situations in their
practice for cases similar to the various scenarios pro-
vided. These treatment profiles therefore combine a
number of healthcare services to make up a “typical”
treatment for each scenario in the study.
Costing each identified resource is the last step.
Although the cost of the resources should normally be
their opportunity cost [67,79], we will in fact be using the
market cost, which is considered to be equivalent [79,80].
Therefore, the value of medical and nursing care will be
based on the salary earned by a physician or health profes-
sional [67,81] while materials required for treatments will
be valued at their purchase price. When it will not be
deemed pertinent to determine the value of a resource
according to the amount spent, because that amount is no
longer representative of its value (as with infrastructures,
for example), we will use the market value [67,81]. Various
data (government statistics, financial reports from health-
care institutions, etc.) will be used to establish resource
costs, which will be set in 2010 dollars. Where appropriate,
a government indexation rate will be applied [67].
Compliance and losses to follow-up
Workshop attendance by control dyads is monitored and
will be used to interpret study findings, as will attendance
of the information session by experimental dyads. Social
workers record the number of meetings held with dyads
that later drop out. Dyads that withdraw their participa-
tion are reached by phone, once, and invited to return to
the Research Center for a follow-up assessment. Posttests
are conducted at home when most convenient for partici-
pants. Those refusing are asked whether they have com-
mitted their preferences in writing and, if so, to provide a
copy of My Preferences completed. Concordance data are
not available from dyads that refuse further involvement
as such data cannot be collected over the phone.
Potential limitations
People who agree to participate may differ to some extent
from those who refuse. In particular, participants may be
more favorable towards ADs - especially research ADs -
than non-participants. Information gathered during the
first telephone contact with prospective subjects will
provide some data to compare participants with those
who decline participation.
Participants are not explicitly informed of the study
hypotheses. However, they cannot be blinded completely
to group assignment. This design feature may exert some
influence on their decision to complete My Preferences.
However, it is unlikely to affect the primary outcome
(prediction accuracy of substitute decisions) since dyad
members are tested in separate rooms with vignettes that
differ in part from those used at baseline. The use of con-
trol dyads partially controls for the Hawthorne effect on
outcome measures. Furthermore, to ensure that partici-
pants who choose to express their preferences in writing
understand the purposes and uses of written ADs, all
participants are administered a brief knowledge question-
naire at the last posttest.
Every effort is made to keep research nurses blind to
group assignment, including instructing participants not
to reveal their group assignment. Unblinding may occur
in some cases but this should not affect results since con-
cordance is assessed by two nurses in separate rooms.
While nurses may inadvertently discover that the dyad
was exposed to the intervention (or not), this knowledge
cannot impact concordance as they are unaware of the
answers given by the other dyad member. Contamination
is highly unlikely since controls do not meet their experi-
mental counterparts and the consent form does not detail
the tested intervention. Co-interventions are also unlikely
given the relatively short duration of the intervention and
scarcity of AD promotional efforts in the province of
Quebec.
Last but not least, hypothetical vignettes do not gener-
ate the emotional reactions that characterize real-life
situations. In addition, preferences may change as a
result of declining health. Despite these drawbacks, the
use of hypothetical scenarios in eliciting preferences for
times of incapacity is common practice in advance care
planning and research on substitute decision-making.
More importantly, the intervention raises participants’
awareness of the importance of updating ADs regularly.
Statistical analyses
Persons who decline participation or drop out will be
compared to trial participants with parametric or non-
parametric two-sample tests (depending on the distribu-
tion of the data) and results used to judge the scope of
study findings. The same tests will be used to compare
participants’ baseline characteristics across study groups.
Potential confounders and compliance indices will be
candidates for adjustment when testing the impact of the
intervention on the outcome measures [82]. All analyses
will be based on allocation to the intervention or control
group (i.e. by intention-to-treat). To account for losses to
follow-up, analyses will be conducted in duplicate, first
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restricting the sample to the dyads for which we have
complete follow-up data, then using a conservative
approach by which dyads that do not provide such data
are assumed not to have documented preferences and
their baseline concordance levels are used for imputation
[83].
The primary analysis will involve calculating composite
scores of agreement across health states for each dyad.
Calculations will generate a total concordance score as
well as sub-scores derived from restricting summations
to the clinical or research vignettes. Growth-curve mod-
eling implemented with SAS PROC MIXED will be used
to compare composite scores across time points and
groups, an approach that accounts for the within-dyad
correlation over time and accommodates missing values
[84,85]. To further elucidate the impact of the interven-
tion, secondary analyses will involve applying the same
statistical procedure to the concordance sub-scores. A
multivariable logistic model will be used to compare
group-specific completion rates of My Preferences 6
months post-intervention. The financial impact of the
intervention will be investigated with Student’s t test for
independent samples or its non-parametric equivalent.
Sample size
We are aiming for 86 dyads per group at study comple-
tion, which would provide 80% power to detect a stan-
dardized difference of 0.43 in overall prediction accuracy
between the study groups (calculation based on the t sta-
tistic, two-sided a = 0.05, nQuery Advisor 6.0). The
expected standardized difference was derived from
Schwartz et al. [31] whose study resembles our own in
many respects. The tested interventions are of compar-
able intensity and duration. Both include an AD educa-
tional component and devote a central role to proxies.
Moreover, in both cases, prediction accuracy is measured
with a composite index derived from combining proxy’s
ability to predict the older adult’s preferences under
various hypothetical scenarios.
Accounting for a drop-out rate of 10% at posttest 1
and 20% at posttest 2, 240 dyads will be randomized. As
indicated in Figure 1, we started the recruitment process
with a random list of 1,000 individuals who fulfill our
first four inclusion criteria. This number should allow
us to reach the target sample size, further accounting
for sampled individuals who will be found ineligible
(e.g., institutionalized or deceased, no longer reside in
the study area, no proxy meeting study criteria), refuse
to be interviewed, or decline study participation.
The above calculations assume that we will compare
groups on posttest mean concordance scores as this
allowed us to use the best available estimate of the likely
effect of the intervention. However, our design involves
repeated measurements of concordance over time that
will be analyzed by growth-curve modeling, a more
sophisticated approach that effectively uses all the avail-
able time points to estimate individual trajectories.
Determination of suitable sample sizes for multilevel
analyses is complex, in part because explicit formulas
have not yet been derived for general models. However,
simulations by Mass & Hox [86] show that between 50
and 100 units per group are needed to justify claims as
to the absence of bias in standard error estimates. As
shown in Figure 1, projected sample sizes are 120 units
per group at baseline, 108 at posttest 1 and 86 at study
completion. Since all data will contribute to some extent
in estimating the model parameters, our approach to
sample size estimation is conservative and protects
against an underpowered study.
Lastly, as shown in Table 1, 86 dyads per group also
provide sufficient power to detect a meaningful differ-
ence between groups for the secondary outcome.
Ethical considerations
The study protocol and materials have been approved by
our Institutional Review Board. This study carries little
risk to participants. Some people may feel uncomfortable
discussing end-of-life treatment preferences or envision-
ing themselves or their loved ones in a state of mental
incapacity. End-of-life issues and decisional incapacity
are sensitive matters for most people. However, the vast
majority welcome opportunities to discuss them and
actually wish that health professionals would raise the
subject. In any event, study participants will be duly
informed of their right to withdraw from the study, at
any time and for any reason, without prejudice.
Discussion
Study results will expand current knowledge on advance
planning by determining whether professionally-led dis-
cussions of preferences improve substitute decision-
making and yield cost savings. Findings will also inform
future public policy and legislation changes by supplying
population-based estimates of the proportion of older
adults who choose to document their wishes regarding
future health care and research participation. Such data
are essential to determine whether the practice of
accepting consent from families in treatment settings
(even lacking prior expressed wishes) should carry over
to research venues [88].
If found effective, subsequent studies could aim at
extending the accessibility of the intervention beyond
study participants. Pamphlets underlying the importance
of intra-familial discussions about end-of-life care and
research participation could be distributed at various loca-
tions (e.g., waiting rooms at health clinics, seniors’ clubs,
residential care facilities) and include a quiz designed to
assess the ability of family members to predict a relative’s
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wishes. During medical checkups, physicians could probe
patients’ interest in advance planning, give copies of My
Preferences to those interested and refer them to a social
worker in charge of delivering the advance planning inter-
vention. However, we must first ensure that the proposed
intervention does in fact significantly enhance substitute
decision-making abilities.
Current study status
Enrollment began in April 2011.
Telephone recruitment interview 
(n = 1,000) 
Refuse to be interviewed 
(40%, n = 200) 
Baseline concordance assessment (n = 240 dyads) 
2 in-person interviews 
Intervention group (n = 120 dyads) 
 Month 1: First home visit 
 Month 2: AD information session 
 Month 3: Second home visit 
Lost to follow-up 
(10%, n = 12 dyads per group) 
First posttest (at the end of the intervention) 
(n = 108 dyads per group) 
Lost to follow-up 
(20%, n = 22 dyads per group) 
Control group (n = 120 dyads) 
 Month 1: First workshop 
 Month 2: Second workshop 
Month 3: Third workshop
Second posttest (6 months post-intervention) 
(n = 86 dyads per group) 
Decline participation 
(20%, n = 60) 
Ineligible 
(50%, n = 500) 
Stratified randomization 
Figure 1 Study subjects flow chart (with estimated sample sizes in parentheses).
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